[18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside), covering 2021-05-11 to 2021-05-11. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety and PET Imaging Characteristics of a Novel Senescence-specific Radiotracer [18F]FPyGal (2-[Fluorine-18]Fluoro-3-pyridinyl-β-D-galactopyranoside) [Phase 1, Phase 2]